Drug or treatment

Nadunolimab clinical trials

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Nadunolimab to prevent progression of high-risk lung nodules

  This trial will test whether nadunolimab can shrink or stop growth of multifocal part-solid high-risk lung nodules in current or former heavy smokers (≥20 pack‑years).

  Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07284485

• Nadunolimab plus azacitidine (± venetoclax) for high-risk MDS and relapsed/refractory AML

  This tests whether adding nadunolimab to azacitidine, with or without venetoclax, helps adults with high-risk MDS or relapsed/refractory AML get better responses and tolerate treatment.

  Recruiting Phase 1/2 M.D. Anderson Cancer Center · Houston, Texas · NCT06548230

Quick answers

How many clinical trials of Nadunolimab are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →